Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study-Reference-Cited by-同舟云学术

Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study

Published:2011-11-16 Issue:11 Volume:32 Page:3565-3572
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Bay-Jensen Anne C.,Leeming Diana J.,Kleyer Arndt,Veidal Sanne S.,Schett Georg,Karsdal Morten A.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-011-2237-8.pdf

Reference43 articles.

1. Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N et al (2009) Biochemical markers and the FDA critical path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers 14(3):181–202

2. Sondergaard BC, Henriksen K, Wulf H, Oestergaard S, Schurigt U, Brauer R et al (2006) Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthr Cartil 14(8):738–748

3. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6(7):399–405

4. Braun J, Pincus T (2002) Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 20(6 Suppl 28):S16–S22

5. Dakwar E, Reddy J, Vale FL, Uribe JS (2008) A review of the pathogenesis of ankylosing spondylitis. Neurosurg Focus 24(1):E2

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis;RMD Open;2024-05

2. Changes in type VI collagen degradation reflect clinical response to treatment in rheumatoid arthritis patients treated with tocilizumab;Arthritis Research & Therapy;2024-01-02

3. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers;RMD Open;2024-01

4. Type II collagen;Biochemistry of Collagens, Laminins and Elastin;2024

5. Type IV collagen;Biochemistry of Collagens, Laminins and Elastin;2024